Page 2 - ஆராய்ச்சி நிறுவனம் க்கு உயிரியல் பாதுகாப்பு ப்ராப்லம்ஸ் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஆராய்ச்சி நிறுவனம் க்கு உயிரியல் பாதுகாப்பு ப்ராப்லம்ஸ். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஆராய்ச்சி நிறுவனம் க்கு உயிரியல் பாதுகாப்பு ப்ராப்லம்ஸ் Today - Breaking & Trending Today

Vaccinations Progress Slowly in Central Asia

Advertisement
Kazakhstan is a regional leader on vaccinations, but that’s not saying terribly much as vaccine rollouts across Asia have proceeded at slow paces relative to Western countries. Meanwhile, reports from Kazakhstan cite bureaucratic hurdles, hesitancy, and a lack of access to data about the country’s domestically-developed vaccine.
To date around 8.3 percent of the Kazakh population, or around 1.4 million people, have received at least one dose of a COVID vaccine. That figure has grown at a steep curve in recent weeks on the back of the availability of domestically produced doses of the Russian vaccine, Sputnik V, in addition to imported doses. ....

United Arab Emirates , South Korea , Lesbek Kutymbetov , Abu Dhabi , Farangis Najibullah , Research Institute For Biological Safety Problems , Research Institute , Biological Safety Problems , Eastern Europe , Soviet Union , ஒன்றுபட்டது அரபு அமீரகங்கள் , தெற்கு கொரியா , ஆராய்ச்சி நிறுவனம் க்கு உயிரியல் பாதுகாப்பு ப்ராப்லம்ஸ் , ஆராய்ச்சி நிறுவனம் , உயிரியல் பாதுகாப்பு ப்ராப்லம்ஸ் , கிழக்கு யூரோப் , சோவியத் தொழிற்சங்கம் ,

Despite Assurances, Some Kazakhs Leery Of Little-Known, Homegrown COVID-19 Vaccine

share
Print
NUR-SULTAN The fact that it hasn t completed its clinical trials hasn t stopped thousands of Kazakh citizens from getting their first shot of the domestically developed coronavirus vaccine QazVac.
The two-dose vaccine is still in its third stage of studies, which are expected to be completed in July. But QazVac s developers the state-backed Research Institute for Biological Safety Problems insists the vaccine is safe and effective.
The institute claims QazVac has shown a 96 percent efficacy against the virus during second-phase testing.
No serious side effects have been reported among the vaccine recipients since the QazVac rollout began on April 26. The Health Ministry says 50,000 doses of QazVac have been distributed across the Central Asian country of nearly 19 million people. ....

Czech Republic , Almaty Qalasy , Lesbek Kutymbetov , Zhanargul Omarova , Farangis Najibullah , Ardak Bukeeva , Viktoria Murzintseva , Asel Musabekova , Aigul Nurlybekova , Rfe Rl Kazakh Service , Research Institute For Biological Safety Problems , Health Ministry , Research Institute , Biological Safety , Central Asian , Chinese Made Sinopharm , செக் குடியரசு , ஆராய்ச்சி நிறுவனம் க்கு உயிரியல் பாதுகாப்பு ப்ராப்லம்ஸ் , ஆரோக்கியம் அமைச்சகம் , ஆராய்ச்சி நிறுவனம் , உயிரியல் பாதுகாப்பு , மைய ஆசிய ,

Not available in Canada: A look at COVID-19 vaccine tech from China, India and Cuba

Posted: May 04, 2021 4:00 AM ET | Last Updated: May 4
A healthcare worker prepares a dose of China s Sinovac Biotech vaccine for the coronavirus disease (COVID-19) at a drive-thru vaccination station, as a mass vaccination program continues in Jakarta, Indonesia, April 30, 2021. It s an inactivated vaccine being used in countries around the world, but not in Canada.(Ajeng Dinar Ulfiana/Reuters) ....

Estado De Pernambuco , Ciudad De La Habana , Craig Laferriere , Colin Funk , Helen Yaffe , Anupam Nath , Bharat Biotch , Sinovac Coronavac , World Health Organization For Emergency Use Listing , Serum Institute Of India Covishield , Queen University , Finlay Institute , World Health Organization , Associated Press , University Of Glasgow , Finlay Institute Of Vaccines , Research Institute For Biological Safety Problems , Serum Institute , Shanghai China , Bharat Biotech , Research Institute , Biological Safety Problems , Emergency Use Listing , Vancouver Based Novateur Ventures , Novateur Ventures , Genetic Engineering ,

Deutsche Welle launches Hungarian service: Emerging Europe this week

Deutsche Welle launches Hungarian service: Emerging Europe this week
April 30, 2021
Central Europe
Bulgaria looks set for a new election after the country’s anti-establishment party, There Is Such A People (ITN), said this week it would not try to form a government despite a surge of support in this month’s parliamentary poll. The populist party – led by singer and TV host Slavi Trifonov – surprisingly finished second in the polls behind only Prime Minister Boyko Borissov’s centre-right GERB party. Popular anger at widespread corruption boosted support for ITN and two smaller anti-graft parties at the April 4 election, but even together the three parties do not have a majority in the fragmented parliament. ITN has ruled out working with Mr Borissov. ....

United States , Vayots Dzor , Czech Republic , Kyrgyzstan General , Black Sea , Oceans General , Aegean Sea , Romania General , City Of , United Kingdom , Qarkui Durresit , Nicolae Ceau , Nikol Pashinyan , Slavi Trifonov , Deutsche Welle , Marufkhan Tulayev , Joe Biden , Boyko Borissov , Gurbanguly Berdymukhammedov , Janez Jan , Deutsche Welle Magyar , Joseph Scrocca , Peter Limbourg , Russian Foreign Ministry , Vienna Insurance Group , Research Institute For Biological Safety Problems ,

Kazakhstan begins using self-developed COVID vaccine

They’re taking their shot. ....

Almaty Qalasy , Alexey Tsoi , Research Institute For Biological Safety Problems , Anadolu Agency , Getty Images , Research Institute , Biological Safety , ஆராய்ச்சி நிறுவனம் க்கு உயிரியல் பாதுகாப்பு ப்ராப்லம்ஸ் , கெட்டி படங்கள் , ஆராய்ச்சி நிறுவனம் , உயிரியல் பாதுகாப்பு ,